Surgical Drainage Devices Market Report by Product, Application, End Use, and Region 2024-2032
세계 외과용 배액 기기 시장 규모는 2023년 18억 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장 규모가 2024-2032년 사이 3.5%의 연평균 성장률(CAGR)을 기록하며 2032년까지 25억 달러에 달할 것으로 예상하고 있습니다.
외과용 배액 기기는 다양한 장기의 내용물, 체강 내 분비물, 혈액, 혈청, 림프액 및 기타 조직액과 같이 수술 후 상처 부위에 축적되는 액체를 제거하는 데 사용됩니다. 이러한 기구는 수술 부위 및 인접한 장기, 신경, 혈관에 대한 압박을 최소화하여 통증을 줄이고 상처의 관류와 치유를 촉진합니다. 요도 카테터, 비위관, 흉강 배액, 감염성 낭종 등에 적용되고 있습니다. 현재 환자의 수술과 상처에 따라 라텍스, 실리콘, 폴리에틸렌, 폴리염화비닐(PVC)을 사용한 다양한 수술용 배액기구가 전 세계적으로 판매되고 있습니다.
외과용 배액 기기 시장 동향
흉부, 림프절, 유방, 복부, 갑상선 관련 수술이 크게 증가하면서 시장 성장을 촉진하는 주요 요인 중 하나입니다. 외과용 배액 기기는 염증 매개체, 박테리아, 이물질 및 괴사 조직을 제거하여 치유 과정을 촉진합니다. 또한, 재건 및 성형 수술을 받으려는 개인들의 의지가 높아지면서 성형 수술에 대한 수요가 증가함에 따라 시장 성장을 촉진하고 있습니다. 이와는 별도로, 외과용 배액 기기는 잠재적인 합병증을 모니터링하고 관류를 손상시키거나 통증을 유발하는 압력을 완화하여 이환율을 낮춥니다. 그 결과, 두개내압 상승 위험이 높은 신경외과 수술과 출혈을 동반한 정형외과 수술의 발생률이 증가하면서 시장 성장에 영향을 미치고 있습니다. 또한, 외과 수술 및 외상성 상처 관리를 위해 수의학 진료에 널리 채택되고 있습니다. 반려동물 사육 증가와 가금류 산업 및 농업의 성장도 시장 성장에 기여하고 있습니다. 또한, 외과 수술에서 배액 장치의 기능 향상과 합병증 감소에 대한 관심이 높아지면서 시장 성장을 견인할 것으로 예상됩니다.
본 보고서에서 다루는 주요 질문들
- 세계 외과용 배액 기기 시장은 지금까지 어떻게 성장해왔으며, 앞으로 어떻게 성장할 것인가?
- COVID-19는 세계 외과용 배액 기기 시장에 어떤 영향을 미쳤을까?
- 주요 지역 시장이란?
- 제품별 시장 분석은?
- 용도별 시장 내역은?
- 최종 용도별 시장 현황은?
- 산업 가치사슬의 다양한 단계는 무엇인가?
- 업계의 주요 촉진요인과 과제는 무엇인가?
- 세계 외과용 배액 기기 시장 구조와 주요 진출기업은?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 외과용 배액 기기 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
- 심장흉부외과
- 신경외과 수술
- 복부 수술
- 정형외과
- 기타
제8장 시장 내역 : 최종 용도별
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 상황
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Acelity L.P. Inc.(3M Company)
- B. Braun Melsungen AG
- Becton Dickinson and Company
- Cardinal Health Inc.
- Cook Group Incorporated
- Johnson & Johnson
- Medela AG
- Medtronic plc
- Smith & Nephew plc
- Stryker Corporation
- Teleflex Incorporated
ksm
The global surgical drainage devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032.
Surgical drainage devices are used to remove the contents of different organs, secretion of body cavities, and blood, serum, lymph, and other tissue fluids that accumulate in wound beds after surgical procedures. These devices minimize pressure on the surgical site and adjacent organs, nerves, and blood vessels, thereby reducing pain and enhancing wound perfusion and healing. They find application in urinary catheters, nasogastric tubes, chest drainage, and infected cysts. Presently, various surgical drainage devices made using latex, silicone, polyethylene, and polyvinyl chloride (PVC) are available worldwide, depending on the patient's surgery and wound.
Surgical Drainage Devices Market Trends:
A significant increase in the number of surgical procedures relating to the chest, lymph node, breast, abdominal, and thyroid represents one of the key factors propelling the market growth. Surgical drainage devices facilitate the healing process by removing inflammatory mediators, bacteria, foreign material, and necrotic tissues. Moreover, the rising demand for plastic surgery due to the increasing willingness among individuals to undergo reconstructive and cosmetic surgeries is bolstering the market growth. Apart from this, surgical drainage devices monitor potential complications and relieve the pressure that can impair perfusion or cause pain, thereby decreasing morbidity. Consequently, the rising incidence of neurosurgery with a high risk of raised intracranial pressure and orthopedic procedures associated with blood loss is influencing the market growth. Furthermore, they are widely being adopted in veterinary practice for surgical or traumatic wound management. The rising adoption of companion animals, along with the flourishing poultry and agriculture industries, is also contributing to market growth. Additionally, the growing focus on improving the functionality and reducing complications associated with drainage devices in surgeries is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical drainage devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Active
Passive
Breakup by Application:
Cardio-Thoracic Surgeries
Neurosurgery Procedures
Abdominal Surgery
Orthopedics
Others
Breakup by End Use:
Hospitals
Clinics
Ambulatory Surgical Centers
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Acelity L.P. Inc. (3M Company), B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Cook Group Incorporated, Johnson & Johnson, Medela AG, Medtronic plc, Smith & Nephew plc, Stryker Corporation and Teleflex Incorporated.
Key Questions Answered in This Report:
- How has the global surgical drainage devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global surgical drainage devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global surgical drainage devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Surgical Drainage Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Active
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Passive
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Cardio-Thoracic Surgeries
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Neurosurgery Procedures
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Abdominal Surgery
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Orthopedics
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End Use
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Acelity L.P. Inc. (3M Company)
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 B. Braun Melsungen AG
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Becton Dickinson and Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Cook Group Incorporated
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Johnson & Johnson
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Medela AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Smith & Nephew plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Stryker Corporation
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Teleflex Incorporated
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
